United States Biotechnology & Medical Research

Aduro Biotech Inc (ADRO)

Ticker: ADRO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aduro Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
King Andrew James Chief Scientific Officer Officer
Transaction date
Sale
Price
55.25
Quantity 78,722 +1.4%
Value US$4,344,381
2.8
Greenman William Mariner Non-Executive Director
Transaction date
Planned sale
Price
366.75
Quantity 9,497 -42.7%
Value US$2,599,084
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Planned sale
Price
174.40
Quantity 11,581 +27.3%
Value US$3,272,134
3.6
ERIC DOBMEIER Officer; Director Executive Director
Transaction date
Proposed sale
Price
21.61
Quantity 25,000
Value US$540,238
2.2
Jerel Davis Non-Executive Director
Transaction date
Sale
Price
20.75
Quantity 295,808 -40.0%
Value US$6,138,223
Krishnan Mahesh Non-Executive Director
Transaction date
Planned sale
Price
23.01
Quantity 924 -42.0%
Value US$21,261
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.34
Quantity 5,000 -22.7%
Value US$116,718
2.2
Jerel Davis Non-Executive Director
Transaction date
Sale
Price
22.75
Quantity 36,751 -14.8%
Value US$836,085
2.2
Jerel Davis Non-Executive Director
Transaction date
Sale
Price
22.75
Quantity 123,249 -14.6%
Value US$2,803,915
2.2
Jerel Davis Non-Executive Director
Transaction date
Sale
Price
22.75
Quantity 240,000 -10.2%
Value US$5,460,000
King Andrew James Chief Scientific Officer Officer
Transaction date
Sale
Price
23.75
Quantity 2,392 -10.9%
Value US$56,806
3.3
BJERKHOLT ERIC Chief Financial Officer Officer
Transaction date
Sale
Price
23.75
Quantity 857 -2.2%
Value US$20,352
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Sale
Price
23.75
Quantity 3,700 -2.4%
Value US$87,869
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Sale
Price
23.75
Quantity 8,097 -2.6%
Value US$192,292
King Andrew James Chief Scientific Officer Officer
Transaction date
Sale
Price
24.68
Quantity 3,244 -17.7%
Value US$80,069
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Sale
Price
24.68
Quantity 4,566 -3.0%
Value US$112,700
3.3
BJERKHOLT ERIC Chief Financial Officer Officer
Transaction date
Sale
Price
24.68
Quantity 2,891 -7.2%
Value US$71,357
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Sale
Price
24.68
Quantity 7,688 -2.6%
Value US$189,757
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Planned sale
Price
24.54
Quantity 25,000 -8.4%
Value US$613,612
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.82
Quantity 10,000 -50.0%
Value US$258,183
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 10,000 -6.5%
Value US$250,005
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Planned sale
Price
22.31
Quantity 30,000 -11.0%
Value US$669,351
3.3
BJERKHOLT ERIC Chief Financial Officer Officer
Transaction date
Sale
Price
22.29
Quantity 5,770 -14.9%
Value US$128,602
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Planned sale
Price
22.16
Quantity 10,000 -6.5%
Value US$221,642
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Sale
Price
19.69
Quantity 7,360 -4.9%
Value US$144,933
King Andrew James Chief Scientific Officer Officer
Transaction date
Sale
Price
19.69
Quantity 3,557 -22.2%
Value US$70,044
Thomas Dolca Non-Executive Director
Transaction date
Purchase
Price
21.20
Quantity 300 +3.1%
Value US$6,360
Thomas Dolca Non-Executive Director
Transaction date
Purchase
Price
21.22
Quantity 9,700 New position
Value US$205,834
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 5,000 -45.9%
Value US$100,000
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.09
Quantity 5,000 -45.9%
Value US$90,468
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
14.00
Quantity 570,000 +12.4%
Value US$7,980,000
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.03
Quantity 5,000 +2.5%
Value US$65,148
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.36
Quantity 5,000 -45.9%
Value US$76,812
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
13.00
Quantity 2,500 -29.8%
Value US$32,500
3.3
BJERKHOLT ERIC Chief Financial Officer Officer
Transaction date
Sale
Price
12.74
Quantity 895 -3.9%
Value US$11,403
Glicklich Alan Chief Medical Officer Officer
Transaction date
Sale
Price
12.74
Quantity 2,391 -23.3%
Value US$30,464
King Andrew James Chief Scientific Officer Officer
Transaction date
Sale
Price
12.74
Quantity 2,498 -22.9%
Value US$31,827
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Sale
Price
12.74
Quantity 3,735 -2.6%
Value US$47,587
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
13.31
Quantity 2,500 -37.9%
Value US$33,275
2.2
Jerel Davis Non-Executive Director Large shareholder
Transaction date
Planned sale
Price
16.00
Quantity 92,000 -14.3%
Value US$1,472,018
2.2
Jerel Davis Non-Executive Director Large shareholder
Transaction date
Planned sale
Price
16.00
Quantity 308,000 -14.2%
Value US$4,928,062
2.2
Jerel Davis Non-Executive Director Large shareholder
Transaction date
Planned sale
Price
16.00
Quantity 600,000 -14.2%
Value US$9,600,120
3.6
AKKARAJU SRINIVAS Non-Executive Director
Transaction date
Purchase
Price
14.00
Quantity 1,215,000 +36.0%
Value US$17,010,000
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Planned sale
Price
15.48
Quantity 6,230 -4.4%
Value US$96,440
King Andrew James Chief Scientific Officer Officer
Transaction date
Planned sale
Price
13.53
Quantity 5,000 -55.0%
Value US$67,660
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Planned sale
Price
15.17
Quantity 13,770 -8.9%
Value US$208,938
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 5,000 -3.1%
Value US$70,000
0.9
Frohlich Tom Chief Operating Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 15,000 -8.6%
Value US$210,000
Glicklich Alan Chief Medical Officer Officer
Transaction date
Planned sale
Price
16.35
Quantity 20,000 -100.0%
Value US$326,968
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
14.44
Quantity 1,000 +1.3%
Value US$14,440
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.08
Quantity 2,000 +3.6%
Value US$26,150
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.24
Quantity 2,000 +3.8%
Value US$26,483
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.67
Quantity 929 +1.8%
Value US$12,699
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.69
Quantity 571 +1.1%
Value US$7,817
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.50
Quantity 500 +1.0%
Value US$6,750
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.75
Quantity 2,500 +5.2%
Value US$34,375
3.6
DOBMEIER ERIC President, CEO Executive Director
Transaction date
Purchase
Price
13.86
Quantity 2,000 +4.3%
Value US$27,720
Ferber Celeste SVP, GC and Secretary Officer
Transaction date
Sale
Price
2.39
Quantity 2,396 -5.8%
Value US$5,731
Templeman Blaine Chief Legal Officer Officer
Transaction date
Sale
Price
2.39
Quantity 12,369 -9.2%
Value US$29,585
ISAACS STEPHEN T President and CEO Executive Director
Transaction date
Sale
Price
2.39
Quantity 32,481 -10.4%
Value US$77,691
Nuyten Dimitry SA Chief Medical Officer Officer
Transaction date
Sale
Price
2.55
Quantity 3,538 -29.5%
Value US$9,036
Ferber Celeste SVP, GC and Secretary Officer
Transaction date
Sale
Price
2.55
Quantity 7,951 -16.2%
Value US$20,308
Templeman Blaine Chief Legal Officer Officer
Transaction date
Sale
Price
2.55
Quantity 7,951 -5.6%
Value US$20,308
van Elsas Andrea Chief Scientific Officer Officer
Transaction date
Sale
Price
3.51
Quantity 6,823 -1.5%
Value US$23,954
van Elsas Andrea Chief Scientific Officer
Transaction date
Sale
Price
1.19
Quantity 73,311 -14.1%
Value US$87,108
Ferber Celeste SVP, GC and Secretary Officer
Transaction date
Sale
Price
1.16
Quantity 408 -1.5%
Value US$475
van Elsas Andrea Chief Scientific Officer Officer
Transaction date
Sale
Price
1.16
Quantity 2,192 -0.4%
Value US$2,550
ISAACS STEPHEN T President and CEO Executive Director
Transaction date
Sale
Price
1.16
Quantity 5,897 -2.0%
Value US$6,860
Templeman Blaine Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.16
Quantity 1,264 -1.1%
Value US$1,470
van Elsas Andrea Chief Scientific Officer
Transaction date
Sale
Price
1.31
Quantity 634 -0.1%
Value US$828
van Elsas Andrea Chief Scientific Officer
Transaction date
Sale
Price
1.31
Quantity 17,959 -3.3%
Value US$23,451
Ferber Celeste SVP, GC and Secretary
Transaction date
Sale
Price
1.31
Quantity 1,102 -3.9%
Value US$1,439
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-01 2023-08-01 S Sale
King Andrew James

Chief Scientific Officer

Officer
78,722 +1.4%
55.25
US$4,344,381 		78,722 +1.4% 55.25 US$4,344,381
2023-05-31 2023-05-30 PlS Planned sale
2.8
Greenman William Mariner
Non-Executive Director
9,497 -42.7%
366.75
US$2,599,084 		9,497 -42.7% 366.75 US$2,599,084
2023-04-26 2023-04-24 PlS Planned sale
3.6
DOBMEIER ERIC

President, CEO

Executive Director
11,581 +27.3%
174.40
US$3,272,134 		11,581 +27.3% 174.40 US$3,272,134
2023-04-24 2023-04-24 PrS Proposed sale
3.6
ERIC DOBMEIER

Officer; Director

Executive Director
25,000
21.61
US$540,238 		25,000 21.61 US$540,238
2023-04-19 2023-04-17 S Sale
2.2
Jerel Davis
Non-Executive Director
295,808 -40.0%
20.75
US$6,138,223 		295,808 -40.0% 20.75 US$6,138,223
2023-04-04 2023-04-04 PlS Planned sale
Krishnan Mahesh
Non-Executive Director
924 -42.0%
23.01
US$21,261 		924 -42.0% 23.01 US$21,261
2023-04-05 2023-04-03 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
5,000 -22.7%
23.34
US$116,718 		5,000 -22.7% 23.34 US$116,718
2023-03-03 2023-03-01 S Sale
2.2
Jerel Davis
Non-Executive Director
36,751 -14.8%
22.75
US$836,085 		36,751 -14.8% 22.75 US$836,085
2023-03-03 2023-03-01 S Sale
2.2
Jerel Davis
Non-Executive Director
123,249 -14.6%
22.75
US$2,803,915 		123,249 -14.6% 22.75 US$2,803,915
2023-03-03 2023-03-01 S Sale
2.2
Jerel Davis
Non-Executive Director
240,000 -10.2%
22.75
US$5,460,000 		240,000 -10.2% 22.75 US$5,460,000
2023-02-15 2023-02-10 S Sale
King Andrew James

Chief Scientific Officer

Officer
2,392 -10.9%
23.75
US$56,806 		2,392 -10.9% 23.75 US$56,806
2023-02-15 2023-02-10 S Sale
3.3
BJERKHOLT ERIC

Chief Financial Officer

Officer
857 -2.2%
23.75
US$20,352 		857 -2.2% 23.75 US$20,352
2023-02-15 2023-02-10 S Sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
3,700 -2.4%
23.75
US$87,869 		3,700 -2.4% 23.75 US$87,869
2023-02-15 2023-02-10 S Sale
3.6
DOBMEIER ERIC

President, CEO

Executive Director
8,097 -2.6%
23.75
US$192,292 		8,097 -2.6% 23.75 US$192,292
2023-02-02 2023-01-31 S Sale
King Andrew James

Chief Scientific Officer

Officer
3,244 -17.7%
24.68
US$80,069 		3,244 -17.7% 24.68 US$80,069
2023-02-02 2023-01-31 S Sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
4,566 -3.0%
24.68
US$112,700 		4,566 -3.0% 24.68 US$112,700
2023-02-02 2023-01-31 S Sale
3.3
BJERKHOLT ERIC

Chief Financial Officer

Officer
2,891 -7.2%
24.68
US$71,357 		2,891 -7.2% 24.68 US$71,357
2023-02-01 2023-01-31 S Sale
3.6
DOBMEIER ERIC

President, CEO

Executive Director
7,688 -2.6%
24.68
US$189,757 		7,688 -2.6% 24.68 US$189,757
2023-02-01 2023-01-30 PlS Planned sale
3.6
DOBMEIER ERIC

President, CEO

Executive Director
25,000 -8.4%
24.54
US$613,612 		25,000 -8.4% 24.54 US$613,612
2023-01-04 2023-01-03 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
10,000 -50.0%
25.82
US$258,183 		10,000 -50.0% 25.82 US$258,183
2022-12-15 2022-12-13 PlS Planned sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
10,000 -6.5%
25.00
US$250,005 		10,000 -6.5% 25.00 US$250,005
2022-12-02 2022-12-01 PlS Planned sale
3.6
DOBMEIER ERIC

President, CEO

Executive Director
30,000 -11.0%
22.31
US$669,351 		30,000 -11.0% 22.31 US$669,351
2022-12-02 2022-12-01 S Sale
3.3
BJERKHOLT ERIC

Chief Financial Officer

Officer
5,770 -14.9%
22.29
US$128,602 		5,770 -14.9% 22.29 US$128,602
2022-11-09 2022-11-07 PlS Planned sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
10,000 -6.5%
22.16
US$221,642 		10,000 -6.5% 22.16 US$221,642
2022-10-11 2022-10-06 S Sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
7,360 -4.9%
19.69
US$144,933 		7,360 -4.9% 19.69 US$144,933
2022-10-11 2022-10-06 S Sale
King Andrew James

Chief Scientific Officer

Officer
3,557 -22.2%
19.69
US$70,044 		3,557 -22.2% 19.69 US$70,044
2022-09-06 2022-09-02 B Purchase
Thomas Dolca
Non-Executive Director
300 +3.1%
21.20
US$6,360 		300 +3.1% 21.20 US$6,360
2022-09-06 2022-09-02 B Purchase
Thomas Dolca
Non-Executive Director
9,700 New position
21.22
US$205,834 		9,700 New position 21.22 US$205,834
2022-08-05 2022-08-04 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
5,000 -45.9%
20.00
US$100,000 		5,000 -45.9% 20.00 US$100,000
2022-07-13 2022-07-11 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
5,000 -45.9%
18.09
US$90,468 		5,000 -45.9% 18.09 US$90,468
2022-06-01 2022-05-27 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
570,000 +12.4%
14.00
US$7,980,000 		570,000 +12.4% 14.00 US$7,980,000
2022-05-27 2022-05-25 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
5,000 +2.5%
13.03
US$65,148 		5,000 +2.5% 13.03 US$65,148
2022-04-13 2022-04-11 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
5,000 -45.9%
15.36
US$76,812 		5,000 -45.9% 15.36 US$76,812
2022-02-23 2022-02-18 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
2,500 -29.8%
13.00
US$32,500 		2,500 -29.8% 13.00 US$32,500
2022-02-14 2022-02-11 S Sale
3.3
BJERKHOLT ERIC

Chief Financial Officer

Officer
895 -3.9%
12.74
US$11,403 		895 -3.9% 12.74 US$11,403
2022-02-14 2022-02-11 S Sale
Glicklich Alan

Chief Medical Officer

Officer
2,391 -23.3%
12.74
US$30,464 		2,391 -23.3% 12.74 US$30,464
2022-02-14 2022-02-11 S Sale
King Andrew James

Chief Scientific Officer

Officer
2,498 -22.9%
12.74
US$31,827 		2,498 -22.9% 12.74 US$31,827
2022-02-14 2022-02-11 S Sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
3,735 -2.6%
12.74
US$47,587 		3,735 -2.6% 12.74 US$47,587
2022-02-11 2022-02-10 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
2,500 -37.9%
13.31
US$33,275 		2,500 -37.9% 13.31 US$33,275
2022-01-05 2022-01-03 PlS Planned sale
Versant Venture Capital VII, L.P.
Large shareholder
92,000 -14.3%
16.00
US$1,472,018 		92,000 -14.3% 16.00 US$1,472,018
2022-01-05 2022-01-03 PlS Planned sale
Versant Venture Capital VII, L.P.
Large shareholder
308,000 -14.2%
16.00
US$4,928,062 		308,000 -14.2% 16.00 US$4,928,062
2022-01-05 2022-01-03 PlS Planned sale
Versant Venture Capital VII, L.P.
Large shareholder
600,000 -14.2%
16.00
US$9,600,120 		600,000 -14.2% 16.00 US$9,600,120
2022-01-05 2022-01-03 PlS Planned sale
2.2
Jerel Davis
Non-Executive Director Large shareholder
92,000 -14.3%
16.00
US$1,472,018 		92,000 -14.3% 16.00 US$1,472,018
2022-01-05 2022-01-03 PlS Planned sale
2.2
Jerel Davis
Non-Executive Director Large shareholder
308,000 -14.2%
16.00
US$4,928,062 		308,000 -14.2% 16.00 US$4,928,062
2022-01-05 2022-01-03 PlS Planned sale
2.2
Jerel Davis
Non-Executive Director Large shareholder
600,000 -14.2%
16.00
US$9,600,120 		600,000 -14.2% 16.00 US$9,600,120
2021-11-17 2021-11-15 B Purchase
3.6
AKKARAJU SRINIVAS
Non-Executive Director
1,215,000 +36.0%
14.00
US$17,010,000 		1,215,000 +36.0% 14.00 US$17,010,000
2021-11-12 2021-11-10 PlS Planned sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
6,230 -4.4%
15.48
US$96,440 		6,230 -4.4% 15.48 US$96,440
2021-11-12 2021-11-09 PlS Planned sale
King Andrew James

Chief Scientific Officer

Officer
5,000 -55.0%
13.53
US$67,660 		5,000 -55.0% 13.53 US$67,660
2021-11-09 2021-11-08 PlS Planned sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
13,770 -8.9%
15.17
US$208,938 		13,770 -8.9% 15.17 US$208,938
2021-11-09 2021-11-05 PlS Planned sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
5,000 -3.1%
14.00
US$70,000 		5,000 -3.1% 14.00 US$70,000
2021-11-09 2021-11-05 PlS Planned sale
0.9
Frohlich Tom

Chief Operating Officer

Officer
15,000 -8.6%
14.00
US$210,000 		15,000 -8.6% 14.00 US$210,000
2021-06-17 2021-06-16 PlS Planned sale
Glicklich Alan

Chief Medical Officer

Officer
20,000 -100.0%
16.35
US$326,968 		20,000 -100.0% 16.35 US$326,968
2021-05-18 2021-05-14 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
1,000 +1.3%
14.44
US$14,440 		1,000 +1.3% 14.44 US$14,440
2020-12-10 2020-12-09 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
2,000 +3.6%
13.08
US$26,150 		2,000 +3.6% 13.08 US$26,150
2020-12-10 2020-12-08 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
2,000 +3.8%
13.24
US$26,483 		2,000 +3.8% 13.24 US$26,483
2020-11-23 2020-11-23 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
929 +1.8%
13.67
US$12,699 		929 +1.8% 13.67 US$12,699
2020-11-23 2020-11-20 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
571 +1.1%
13.69
US$7,817 		571 +1.1% 13.69 US$7,817
2020-11-23 2020-11-19 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
500 +1.0%
13.50
US$6,750 		500 +1.0% 13.50 US$6,750
2020-11-13 2020-11-11 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
2,500 +5.2%
13.75
US$34,375 		2,500 +5.2% 13.75 US$34,375
2020-11-13 2020-11-10 B Purchase
3.6
DOBMEIER ERIC

President, CEO

Executive Director
2,000 +4.3%
13.86
US$27,720 		2,000 +4.3% 13.86 US$27,720
2020-09-17 2020-09-15 S Sale
Ferber Celeste

SVP, GC and Secretary

Officer
2,396 -5.8%
2.39
US$5,731 		2,396 -5.8% 2.39 US$5,731
2020-09-17 2020-09-15 S Sale
Templeman Blaine

Chief Legal Officer

Officer
12,369 -9.2%
2.39
US$29,585 		12,369 -9.2% 2.39 US$29,585
2020-09-17 2020-09-15 S Sale
ISAACS STEPHEN T

President and CEO

Executive Director
32,481 -10.4%
2.39
US$77,691 		32,481 -10.4% 2.39 US$77,691
2020-08-11 2020-08-07 S Sale
Nuyten Dimitry SA

Chief Medical Officer

Officer
3,538 -29.5%
2.55
US$9,036 		3,538 -29.5% 2.55 US$9,036
2020-08-11 2020-08-07 S Sale
Ferber Celeste

SVP, GC and Secretary

Officer
7,951 -16.2%
2.55
US$20,308 		7,951 -16.2% 2.55 US$20,308
2020-08-11 2020-08-07 S Sale
Templeman Blaine

Chief Legal Officer

Officer
7,951 -5.6%
2.55
US$20,308 		7,951 -5.6% 2.55 US$20,308
2020-02-26 2020-02-25 S Sale
van Elsas Andrea

Chief Scientific Officer

Officer
6,823 -1.5%
3.51
US$23,954 		6,823 -1.5% 3.51 US$23,954
2020-01-06 2020-01-03 S Sale
van Elsas Andrea

Chief Scientific Officer
73,311 -14.1%
1.19
US$87,108 		73,311 -14.1% 1.19 US$87,108
2019-12-16 2019-12-12 S Sale Ferber Celeste

SVP, GC and Secretary

Officer
408 -1.5%
1.16
US$475 		408 -1.5% 1.16 US$475
2019-12-16 2019-12-12 S Sale van Elsas Andrea

Chief Scientific Officer

Officer
2,192 -0.4%
1.16
US$2,550 		2,192 -0.4% 1.16 US$2,550
2019-12-16 2019-12-12 S Sale ISAACS STEPHEN T

President and CEO

Executive Director
5,897 -2.0%
1.16
US$6,860 		5,897 -2.0% 1.16 US$6,860
2019-12-16 2019-12-12 PlS Planned sale Templeman Blaine

Chief Legal Officer

Officer
1,264 -1.1%
1.16
US$1,470 		1,264 -1.1% 1.16 US$1,470
2019-09-17 2019-09-13 S Sale
van Elsas Andrea

Chief Scientific Officer
634 -0.1%
1.31
US$828 		634 -0.1% 1.31 US$828
2019-09-17 2019-09-13 S Sale
van Elsas Andrea

Chief Scientific Officer
17,959 -3.3%
1.31
US$23,451 		17,959 -3.3% 1.31 US$23,451
2019-09-17 2019-09-13 S Sale
Ferber Celeste

SVP, GC and Secretary
1,102 -3.9%
1.31
US$1,439 		1,102 -3.9% 1.31 US$1,439

See older Aduro Biotech Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Aduro Biotech Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Aduro Biotech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America